Crossmark

Development and validation of a discrimination model between primary PLA2R-negative membranous nephropathy and minimal change disease confirmed by renal biopsy

Crossref DOI link: https://doi.org/10.1038/s41598-021-97517-8

Published Online: 2021-09-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Feng

Zhang, Yiding

Cui, Wen

Dong, Yijun

Geng, Yingyang

Liu, Changhao

Li, Zemeng

Xie, Yandong

Cai, Xiaojing

Shang, Jin

Xiao, Jing

Zhao, Zhanzheng
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81873611, 81700633)

Science and Technology Innovation Team of Henan (17IRTSTHN020)

Foundation for Leading Personnel of Central Plains of China (194200510006)

Medical Science and Technology Public Relations Plan of Henan (LHGJ20190241)
License Information

Text and Data Mining valid from 2021-09-10

Version of Record valid from 2021-09-10
More Information

Article History

Received: 11 April 2021

Accepted: 25 August 2021

First Online: 10 September 2021

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below